Commercial & delivery excellence CMO — Pharma & Biotech (USA)

Position overview

Gladwin International Leadership Advisors is representing a confidential organisation in Pharmaceuticals & Biotechnology on a senior CMO leadership mandate anchored in USA. The remit explicitly spans Malaysia, Australia, India.

This is a P&L-owning regional leadership mandate with full accountability for revenue, margin, talent, and governance across the defined geography.

Expect a mandate where credibility is earned in rooms with customers and regulators, not only in headquarters workshops.

Context you will inherit

• Market & sector: Market access and pricing — as governments globally drive price controls, finding leaders who can manage market access, pricing strategy, and government affairs with sophistication
• Geographic spine: Primary hub USA with explicit corridor responsibility across Malaysia, Australia, India.
• Organisation stage: ESG and conduct expectations from owners and regulators are now hard constraints on how growth is pursued.
• Stakeholders: Owners may include PE operating partners, a promoter family office, or public-market investors — each with different tempo and KPIs.
• Secondary lens: Biosimilars and specialty pharma commercialisation — moving from commoditised generics to branded specialty requires entirely new commercial leadership capabilities

The mandate (12–24 month arc)

1. Growth playbook: Define repeatable plays for new logo acquisition, cross-sell, and retention in priority verticals.
2. Content & thought leadership: Elevate executive visibility in forums that matter to buyers and regulators (where relevant).
3. Pricing & packaging: Partner with sales and product on packaging that reflects value, not internal cost structures.
4. Marketing organisation: Structure team around journeys and segments — reduce silos between brand, demand, and comms.
5. Crisis & reputation: Build protocols and narratives for high-stakes communications scenarios.
6. Measurement: Tie marketing KPIs to revenue proxies the CFO and CEO will accept.

Responsibilities (representative)

• Build product marketing capability tied to roadmap and revenue plays.
• Improve marketing ROI measurement — acceptable proxies where full attribution is impossible.
• Develop partner and channel marketing where indirect routes dominate.
• Instil crisis communications readiness with legal and corporate affairs.
• Coach the organisation on narrative discipline — one story, many channels.

Leadership profile

• Judgment: High signal-to-noise under pressure; ethical clarity; willingness to halt initiatives that break risk appetite.
• Modern marketing: Fluency with data, segmentation, and accountable spend — not only creative excellence.
• Education: Strong undergraduate grounding; MBA / advanced degree / professional qualification common at this level.
• Communication: Executive presence in English; additional languages valued where market-relevant.
• Geographic muscle: Comfort operating from USA with regular engagement across Malaysia, Australia.

Team & culture

The organisation runs hot — ambitious targets and thin buffers. You need to channel energy into sustainable rhythms: predictable planning, honest risk surfacing, and recovery time for teams after major pushes.

Success measures (examples)

• Value creation: EBITDA / cash trajectory vs. owner or board case — especially under stress scenarios.
• Execution: On-time delivery of named transformation milestones; reduction in repeat incidents or audit findings.
• Leadership: External hires and internal promotions that stick; reduction in key-person concentration.
• Innovation: Launched offers or capabilities that move the needle on differentiation, not pilots that stall.

First 90 days (orientation arc)

• Days 1–30: Map cash, covenant, and customer concentration risks before announcing initiatives.
• Days 30–60: Align owners and board on a 12-month value story — financial and non-financial.
• Days 60–90: Launch two quick operational fixes that build credibility with frontline managers.
• Deep-dive on talent — who is load-bearing, who is blocking, where external hire is mandatory.
• Socialise a simple KPI tree so every function sees how their metrics roll up.

Stakeholder map (illustrative)

• Internal: Executive committee, functional peers, shared services leads, and programme PMOs.
• External: Key suppliers, technology partners, and joint-venture boards where applicable.
• Board / owners: Expect deep dives on risk, liquidity, talent, and transformation — slides light, substance heavy.

Travel & mobility

Travel weighted to priority markets and quarterly global or regional forums; flexibility for crisis windows.

Compensation

Package aligned to CMO benchmarks in Pharmaceuticals & Biotechnology — typically fixed, variable, benefits, and mobility where applicable. Structure detailed at shortlist.

Application status

This mandate is no longer accepting new applications. The search progressed through Q4 2025 and closed for submissions in February 2026. We retain this posting for transparency on the type of leadership work we carry in Pharmaceuticals & Biotechnology and USA. For similar active mandates, browse open roles or submit a general profile through executive search inquiry.

Reference: pharmaceuticals-biotech · CMO · USA · Gladwin International Leadership Advisors